| AML | Acute myeloid leukaemia |
| CR | Complete remission |
| CRc | Composite complete remission |
| CRi | Complete remission with incomplete haematological response |
| CRp | Complete remission with incomplete platelet count |
| FLT3L | FLT3 ligand |
| HSCT | Haematopoietic stem cell transplantation |
| HSPC | Haematopoietic stem and progenitor cell |
| ITD | Internal tandem duplication |
| OME | Omacetaxine mepesuccinate |
| PR | Partial response |
| R/R | Relapse or refractory |
| TKD | Tyrosine kinase domain |
| TKI | Tyrosine kinase inhibitor |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.